HOME >> BIOLOGY >> NEWS
UT Southwestern physician-researcher wins international award for lipid research

DALLAS Dr. Helen Hobbs, director of the Eugene McDermott Center for Human Growth and Development and an investigator in the Howard Hughes Medical Institute at UT Southwestern Medical Center, has been awarded Germany's highly respected Heinrich Wieland Prize for her research on lipids.

The prestigious international science award is given annually to an individual who has conducted outstanding research in the fields of biochemistry, chemistry and physiology of fats and lipids and its clinical importance.

Dr. Hobbs' research focuses on the genetics of lipid metabolism, such as inherited factors that play a role in determining the level of low-density lipoproteins (LDL), or "bad" cholesterol, in the blood. High LDL cholesterol is a major risk factor for heart disease, heart attack and stroke because it contributes to the buildup of plaque that clogs the walls of arteries. Dr. Hobbs' research has shown, for example, that at least one out of every 50 blacks has a variation in one particular gene that results in a 40 percent-lower level of LDL.

The award is named after German chemist Dr. Heinrich Otto Wieland (1877-1957), who won the Nobel Prize in 1927 for his work on bile acids. Dr. Hobbs' work provides new insights on how cholesterol gets into bile, which is the major method used by the human body to eliminate cholesterol.

"Helen Hobbs is the poster child for physician scientists," said Dr. Michael Brown, Nobel laureate and director of the Erik Jonsson Center for Research in Molecular Genetics and Human Disease at UT Southwestern. In the 1980s, Dr. Hobbs spent four years following her clinical training as a postdoctoral research fellow in Dr. Brown and fellow Nobel laureate Dr. Joseph Goldstein's laboratory at UT Southwestern.

"An outstanding clinician, she launched her scientific career with Joe and me, and then she went ballistic. Her recent genetic work on human cholesterol-lowering mutations is the most important work in chol
'"/>

Contact: Amanda Siegfried
amanda.siegfried@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
4-Nov-2005


Page: 1 2 3

Related biology news :

1. UT Southwestern joins national clinical trial to uncover long-term effects of West Nile virus
2. UT Southwestern leaders to receive national award for medical research accomplishments
3. UT Southwestern scientist receives NIH Directors Pioneer Award
4. UT Southwestern scientist named Keck Foundation Distinguished Young Scholar in Medical Research
5. UT Southwestern researchers find gene mutation that leads to broken hearts
6. Plague agent helps UT Southwestern researchers find novel signaling system in cells
7. One of the nations first 7-Tesla magnetic resonance imaging devices for human studies planned at UT Southwestern Medical Center
8. DNA end caps may lead to cancer treatments, UT Southwestern researchers report
9. UT Southwestern scientist honored among best in Texas research
10. UT Southwestern scientist receives international award for pediatric research
11. UT Southwestern scientist elected to National Academy of Sciences Institute of Medicine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/4/2019)... , ... October 04, 2019 , ... ... will be held November 10 at the Grand Elysée Hamburg Rothenbaumchaussee in Hamburg. ... Europe again this November,” said Miao Guo, Vice President of Operations and spokesperson ...
(Date:10/3/2019)... ... October 01, 2019 , ... The ... of chemicals, reagents, and medias and to be a more environmentally sustainable evolution ... culmination of years of experience and feedback from the original version we launched ...
(Date:10/3/2019)... ... 02, 2019 , ... Connecticut Innovations (CI), Connecticut’s strategic venture ... innovative, growing companies, today announced that it has closed on a $750,000 investment ... the 2018 VentureClash competition. , The outlay is part of ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 02, 2019 , ... Rapid Novor, Inc., ... announce that it has moved into a new, 5000 sqft, purpose-built, state-of-the-art facility. ... facility demonstrates the company's continuous commitment to quality research and service offerings. ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer ... focused on the development of therapies to treat central nervous system (CNS) ...
(Date:9/17/2019)... ... 2019 , ... Catalent, a global leader in clinical supply ... Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials in ... Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney will present “Singapore: APAC’s Clinical ...
(Date:9/17/2019)... (PRWEB) , ... September 16, 2019 , ... ... Nationwide via CNBC on Saturday, September 21st @11:00am ET. Check local listings for ... Pte. Ltd. (Credo Biomedical), a molecular diagnostic company from Singapore dedicated to ...
Breaking Biology Technology:
Cached News: